In patients without left ventricular dysfunction and/or overt HF, three large studies (Heart Outcomes Prevention Evaluation, HOPE trial,3 the European trial on Reduction Of cardiac events with ...

European Heart Journal - Cardiovascular Pharmacotherapy, EDITORIAL, Stefania Paolillo, Pasquale Perrone Filardi